BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22392065)

  • 21. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation.
    Yamamoto K; Ohishi M; Ho C; Kurtz TW; Rakugi H
    Hypertension; 2009 Dec; 54(6):1353-9. PubMed ID: 19822796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M; Jiménez A; Núñez A; López-Blaya A; Farré J; Gómez J; Zalba LR; Sánchez de Miguel L; Casado S; López-Farré A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):906-13. PubMed ID: 10836725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
    Kanome T; Watanabe T; Nishio K; Takahashi K; Hongo S; Miyazaki A
    Hypertens Res; 2008 Sep; 31(9):1801-10. PubMed ID: 18971559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II.
    Takata Y; Chu V; Collins AR; Lyon CJ; Wang W; Blaschke F; Bruemmer D; Caglayan E; Daley W; Higaki J; Fishbein MC; Tangirala RK; Law RE; Hsueh WA
    Circ Res; 2005 Oct; 97(9):e88-96. PubMed ID: 16224068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars].
    Liu HW; Cheng B; Wu HJ; Gu YF; Chen X; Chen ZG; Liu WZ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Jan; 26(1):57-60. PubMed ID: 20432929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Kagaya H; Saito M; Inoue T; Ohkubo T; Habuchi T; Suzuki T
    J Clin Pharm Ther; 2009 Dec; 34(6):683-92. PubMed ID: 20175802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.
    Li JM; Mogi M; Tsukuda K; Tomochika H; Iwanami J; Min LJ; Nahmias C; Iwai M; Horiuchi M
    Mol Endocrinol; 2007 Feb; 21(2):499-511. PubMed ID: 17068200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.
    Hasan AU; Ohmori K; Hashimoto T; Kamitori K; Yamaguchi F; Ishihara Y; Ishihara N; Noma T; Tokuda M; Kohno M
    Hypertens Res; 2014 Jul; 37(7):621-8. PubMed ID: 24599011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.
    Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J
    Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
    Siragy HM; Xue C; Abadir P; Carey RM
    Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the cell membrane angiotensin AT2 receptors in human leiomyosarcoma cells induces differentiation and apoptosis by a PPARγ - dependent mechanism.
    LÜtzen U; Zhao Y; Lucht K; Zuhayra M; Hedderich J; Cascorbi I; Culman J
    Neoplasma; 2017; 64(3):395-405. PubMed ID: 28253719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: findings from in vitro and ex vivo studies.
    Ozasa H; Ayaori M; Iizuka M; Terao Y; Uto-Kondo H; Yakushiji E; Takiguchi S; Nakaya K; Hisada T; Uehara Y; Ogura M; Sasaki M; Komatsu T; Horii S; Mochizuki S; Yoshimura M; Ikewaki K
    Atherosclerosis; 2011 Nov; 219(1):141-50. PubMed ID: 21862012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT
    Justin A; Divakar S; Ramanathan M
    Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation.
    Janke J; Schupp M; Engeli S; Gorzelniak K; Boschmann M; Sauma L; Nystrom FH; Jordan J; Luft FC; Sharma AM
    J Hypertens; 2006 Sep; 24(9):1809-16. PubMed ID: 16915030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
    Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.